Roobol MJ - Search Results

1

Introducing PIONEER: a project to harness big data in prostate cancer research.

Omar MI, Roobol MJ, Ribal MJ, Abbott T, Agapow PM, Araujo S, Asiimwe A, Auffray C, Balaur I, Beyer K, Bernini C, Bjartell A, Briganti A, Butler-Ransohoff JE, Campi R, Cavelaars M, De Meulder B, Devecseri Z, Voss MD, Dimitropoulos K, Evans-Axelsson S, Franks B, Fullwood L, Horgan D, Smith EJ, Kiran A, Kivinummi K, Lambrecht M, Lancet D, Lindgren P, MacLennan S, MacLennan S, Nogueira MM, Moen F, Moinat M, Papineni K, Reich C, Reiche K, Rogiers S, Sartini C, van Bochove K, van Diggelen F, Van Hemelrijck M, Van Poppel H, Zong J, N'Dow J; PIONEER Consortium. Omar MI, et al. Among authors: roobol mj. Nat Rev Urol. 2020 Jun;17(6):351-362. doi: 10.1038/s41585-020-0324-x. Epub 2020 May 27. Nat Rev Urol. 2020. PMID: 32461687 Review.

2

A more advanced clinical stage is positively correlated with an increased prostate cancer detection rate.

Roobol MJ, Kranse R, van der Cruijsen IW, Schröder FH. Roobol MJ, et al. Urology. 2002 Jan;59(1):91-6. doi: 10.1016/s0090-4295(01)01479-0. Urology. 2002. PMID: 11796288 Clinical Trial.

3

Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.

Raaijmakers R, Wildhagen MF, Ito K, Pàez A, de Vries SH, Roobol MJ, Schröder FH. Raaijmakers R, et al. Among authors: roobol mj. Urology. 2004 Feb;63(2):316-20. doi: 10.1016/j.urology.2003.09.028. Urology. 2004. PMID: 14972481

4

The story of the European Randomized Study of Screening for Prostate Cancer.

Schröder FH, Denis LJ, Roobol M, Nelen V, Auvinen A, Tammela T, Villers A, Rebillard X, Ciatto S, Zappa M, Berenguer A, Paez A, Hugosson J, Lodding P, Recker F, Kwiatkowski M, Kirkels WJ; ERSPC. Schröder FH, et al. BJU Int. 2003 Dec;92 Suppl 2:1-13. doi: 10.1111/j.1464-410x.2003.04389.x. BJU Int. 2003. PMID: 14983946 Review. No abstract available.

5

Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml: value of percent free prostate specific antigen on tumor detection and tumor aggressiveness.

Raaijmakers R, Blijenberg BG, Finlay JA, Rittenhouse HG, Wildhagen MF, Roobol MJ, Schröder FH. Raaijmakers R, et al. Among authors: roobol mj. J Urol. 2004 Jun;171(6 Pt 1):2245-9. doi: 10.1097/01.ju.0000127731.56103.50. J Urol. 2004. PMID: 15126795

6

Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.

van der Cruijsen-Koeter IW, Vis AN, Roobol MJ, Wildhagen MF, de Koning HJ, van der Kwast TH, Schröder FH. van der Cruijsen-Koeter IW, et al. Among authors: roobol mj. J Urol. 2005 Jul;174(1):121-5. doi: 10.1097/01.ju.0000162061.40533.0f. J Urol. 2005. PMID: 15947595 Clinical Trial.

7

Does PSA velocity predict prostate cancer in pre-screened populations?

Schröder FH, Roobol MJ, van der Kwast TH, Kranse R, Bangma CH. Schröder FH, et al. Among authors: roobol mj. Eur Urol. 2006 Mar;49(3):460-5; discussion 465. doi: 10.1016/j.eururo.2005.12.026. Epub 2006 Jan 17. Eur Urol. 2006. PMID: 16442212

8

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.

Roemeling S, Roobol MJ, Postma R, Gosselaar C, van der Kwast TH, Bangma CH, Schröder FH. Roemeling S, et al. Among authors: roobol mj. Eur Urol. 2006 Sep;50(3):475-82. doi: 10.1016/j.eururo.2006.04.019. Epub 2006 May 3. Eur Urol. 2006. PMID: 16713065

9

Prostate cancer in the Swedish section of ERSPC--evidence for less metastases at diagnosis but not for mortality reduction.

Schröder FH, Habbema DF, Roobol MJ, Bangma CH. Schröder FH, et al. Among authors: roobol mj. Eur Urol. 2007 Mar;51(3):588-90. doi: 10.1016/j.eururo.2006.07.013. Epub 2006 Jul 28. Eur Urol. 2007. PMID: 16911853 No abstract available.

10

Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam.

van der Cruijsen-Koeter IW, Roobol MJ, Wildhagen MF, van der Kwast TH, Kirkels WJ, Schröder FH. van der Cruijsen-Koeter IW, et al. Among authors: roobol mj. Urology. 2006 Sep;68(3):615-20. doi: 10.1016/j.urology.2006.03.015. Urology. 2006. PMID: 17010732 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

486 results

Search Page